InvestorsHub Logo
Followers 30
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: None

Wednesday, 03/02/2016 2:40:02 PM

Wednesday, March 02, 2016 2:40:02 PM

Post# of 402396
http://www.medpagetoday.com/Washington-Watch/FDAGeneral/56502

FDA Science Advisors Talk Strategy on Opioids


Califf also recapitulated the agency's latest action on opioids, which included convening the current meeting, as well as changes to immediate-release opioid labeling; advisory committees for all opioids that don't have abuse-deterrent formulations; and additional post-marketing study requirements.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News